Academic publications, Scottish Government reports and other outputs from the EAVE II study
The study is led by Professor Aziz Sheikh at the University of Edinburgh, and runs a Public Advisory Group (PAG)
- Quick Access List
- Impact on emergency and elective hospital-based care in Scotland over the first year of the pandemic
- Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II)
- Vaccine Effectiveness of Two-Dose BNT162b2 Over Time Against COVID-19 Symptomatic Infection and Severe Cases Among Adolescents
- BNT162b2 and ChAdOx1 nCoV-19 Vaccinations, Incidence of SARS-CoV-2 Infections and COVID-19 Hospitalisations in Scotland in the Delta era